Table 6.

Association (95% CIs) between prenatal exposure to BDE-153 and indices of neurodevelopment at 12, 24, 36, 48, and 72 months of age.

					Model 2b
	Age (months)	n	Univariate Change in score per ln-unit	Model 1a Change in score per ln-unit	Change in score per ln-unit	Change in score per increase from the 25th to 75th percentile (IQRc)
MDI	12	111	−0.24 (−1.74 to 1.26)	0.05 (−1.59 to 1.69)	0.02 (−1.65 to 1.68)	0.02 (−1.51 to 1.54)
	24	113	−0.42 (−2.90 to 2.06)	−1.26 (−3.68 to 1.17)	−1.71 (−4.07 to 0.65)	−1.57 (−3.73 to 0.60)
	36	107	1.78 (−0.54 to 4.09)	0.29 (−2.17 to 2.75)	−0.05 (−2.46 to 2.37)	−0.05 (−2.25 to 2.17)
PDI	12	111	−1.44 (−3.65 to 0.77)	−2.02 (−4.37 to 0.33)	−1.95 (−4.34 to 0.43)	−1.79 (−3.98 to 0.39)
	24	111	0.90 (−1.12 to 2.92)	1.20 (−1.03 to 3.44)	1.21 (−1.06 to 3.49)	1.11 (−0.97 to 3.20)
	36	102	−0.04 (−2.62 to 2.54)	0.04 (−2.96 to 3.05)	0.03 (−3.00 to 3.05)	0.03 (−2.75 to 2.79)
Full	48	97	−0.30 (−3.14 to 2.55)	−2.69 (−5.17 to −0.21)*	−3.09 (−5.64 to −0.54)*	−2.83 (−5.17 to −0.49)*
	72	92	0.02 (−3.28 to 3.32)	−3.40 (−6.57 to −0.22)*	−3.25 (−6.35 to −0.15)*	−2.98 (−5.82 to −0.14)*
Verbal	48	97	0.24 (−2.63 to 3.12)	−1.93 (−4.71 to 0.85)	−2.46 (−5.32 to 0.41)	−2.25 (−4.87 to 0.38)
	72	92	1.74 (−1.82 to 5.29)	−1.91 (−5.28 to 1.47)	−1.79 (−5.05 to 1.47)	−1.64 (−4.63 to 1.35)
Performance	48	97	−1.22 (−4.37 to 1.92)	−3.46 (−6.36 to −0.57)*	−3.62 (−6.62 to −0.63)*	−3.32 (−6.07 to −0.58)*
	72	92	−2.03 (−5.23 to 1.17)	−4.35 (−7.63 to −1.06)*	−4.19 (−7.48 to −0.89)*	−3.84 (−6.85 to −0.82)*

^aModel 1 adjusted for age at testing, race/ethnicity, IQ of mother, sex of child, gestational age at birth, maternal age, ETS (yes/no), maternal education, material hardship, and breast-feeding.

^bModel 2 adjusted for all covariates in model 1 plus language and location of interview.

^cIQR for BDE-153 is 0.85 ng/g lipid.

^*CIs do not include 0.00.